Protein kinase inhibitor-mediated immunoprophylactic and immunotherapeutic control of colon cancer

HIGHLIGHTS

• who: Silvia Ghione et al. from the Research Centers, Germany Pham Ngoc Thach University of have published the article: Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer, in the Journal: (JOURNAL)
• what: The authors report that the KI H89 delays the development of endogenous colon carcinogenesis and reduces the growth of other transplantable mouse models of colon cancer, which rely on the activation of NK and T-cell antitumor response, respectively. The authors demonstrate that the kinase inhibitor H89 not only delays the manifestation of tumors when used as a prophylactic intervention . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.